Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma

PO-97.

  • Kubo, Shuji
  • Tamamoto, Atsuko
  • Tamaoki, Tomoko
  • Terada, Nobuyuki
  • Maeyama, Yoshihiro
  • Okamura, Haruki
  • Kasahara, Noriyuki

  • 1Department of Genetics,

    2Department of Pathology,

    3Laboratory of Tumor Immunology, Hyogo College of Medicine, Nishinomiya,

    4Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, USA

The Journal of Gene Medicine 16(8):p 270, July-August 2014.
Copyright © 2014 John Wiley & Sons, Ltd
View full text|Download PDF